Roux F, Boyer E, Jaulhac B, Dernis E, Closs-Prophette F, Puéchal X
Service de Rhumatologie, Centre Hospitalier du Mans, 194 avenue Rubillard, 72000, Le Mans, France.
Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):685-93. doi: 10.1007/s10096-007-0347-8.
The symptoms of Lyme meningoradiculitis and the value of biological examinations in an endemic area were determined in a prospective study in which data were collected on all patients consecutively hospitalised for Lyme meningoradiculitis at our institution during an 18-month period. Specific antibody titres in the serum and cerebrospinal fluid (CSF) were determined by Vidas enzyme-linked-immunosorbent-assay (IgG + IgM), Dade-Behring enzyme immunoassay (EIA) (IgM; IgG) and Western blot analysis (IgG). We also searched for Borrelia burgdorferi in the CSF by PCR analysis and following culture on a specific medium. A control group was recruited, consisting of 16 consecutive patients who had been referred during the same period with suspected but not confirmed Lyme meningoradiculitis. Eleven patients were included. Borrelia EIA of the serum revealed that 40% of the patients had both elevated specific IgM titres and intrathecal synthesis of specific IgG; 40% of the patients was negative for IgM but had isolated intrathecal synthesis of IgG; 20% of the patients had elevated specific IgM titres without intrathecal synthesis of IgG. PCR analysis and the CSF culture were positive in one case only (B. garinii). The results of this study highlight the importance of systematic serological testing for B. burgdorferi in the CSF in the case of early neuroborreliosis suspicion, even in the absence of IgM serum antibodies, which was the case in 40% of the patients in the present study. Nevertheless, intrathecal anti-B. burgdorferi IgG synthesis, which remains the "gold standard" for the diagnosis of neuroborreliosis, was not detectable in 20% of the patients for whom diagnosis was subsequently confirmed by demonstration of specific serum IgM.
在一项前瞻性研究中,我们确定了莱姆脑膜神经根炎的症状以及在流行地区进行生物学检查的价值。该研究收集了我们机构在18个月期间连续住院的所有莱姆脑膜神经根炎患者的数据。通过Vidas酶联免疫吸附测定法(IgG + IgM)、Dade-Behring酶免疫测定法(EIA)(IgM;IgG)和蛋白质印迹分析(IgG)测定血清和脑脊液(CSF)中的特异性抗体滴度。我们还通过PCR分析以及在特定培养基上培养后在脑脊液中寻找伯氏疏螺旋体。招募了一个对照组,由同期转诊的16例疑似但未确诊莱姆脑膜神经根炎的连续患者组成。纳入了11例患者。血清伯氏疏螺旋体EIA显示,40%的患者特异性IgM滴度升高且鞘内合成特异性IgG;40%的患者IgM为阴性,但有孤立的鞘内IgG合成;20%的患者特异性IgM滴度升高但无鞘内IgG合成。PCR分析和脑脊液培养仅在1例中呈阳性(加氏疏螺旋体)。本研究结果强调,在怀疑早期神经型莱姆病时,即使在没有血清IgM抗体的情况下(本研究中40%的患者为此种情况),对脑脊液中的伯氏疏螺旋体进行系统血清学检测也很重要。然而,在20%随后通过特异性血清IgM证实诊断的患者中,未检测到鞘内抗伯氏疏螺旋体IgG合成,而鞘内抗伯氏疏螺旋体IgG合成仍是神经型莱姆病诊断的“金标准”。